Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 237.50 INR
Change Today -2.00 / -0.84%
Volume 106.7K
JBCP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

j.b. chemicals & pharma ltd (JBCP) Snapshot

Open
239.85
Previous Close
239.50
Day High
242.20
Day Low
236.60
52 Week High
04/15/15 - 268.50
52 Week Low
07/14/14 - 148.40
Market Cap
20.1B
Average Volume 10 Days
231.3K
EPS TTM
11.84
Shares Outstanding
84.8M
EX-Date
--
P/E TM
20.1x
Dividend
4.00
Dividend Yield
1.26%
Current Stock Chart for J.B. CHEMICALS & PHARMA LTD (JBCP)

Related News

No related news articles were found.

j.b. chemicals & pharma ltd (JBCP) Related Businessweek News

No Related Businessweek News Found

j.b. chemicals & pharma ltd (JBCP) Details

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and APIs in India. The company offers generic products and formulations in the form of tablets, capsules, creams and ointments, injectables, liquid herbal syrups, and lozenges. It also manufactures iodinated contrast media, which are radiopaque substances used to study internal structures of the body in X-ray procedures, such as computed tomography and cardiac catheterization. In addition, the company’s APIs include atenolol USP, cilnidipine, diclofenac acid, and diclofenac diethylamine BP/EP. Further, it provides contract manufacturing services to pharmaceutical companies. The company also exports its products primarily to Russia, Ukraine, CIS countries, and South Africa. J. B. Chemicals & Pharmaceuticals Limited was founded in 1976 and is headquartered in Mumbai, India.

Founded in 1976

j.b. chemicals & pharma ltd (JBCP) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 16.0M
President, Director of Operations and Whole-T...
Total Annual Compensation: 7.7M
Director of Technical & Production and Execut...
Total Annual Compensation: 4.4M
Director of Administration, Whole-Time Direct...
Total Annual Compensation: 16.0M
Director of Planning & Development and Whole-...
Total Annual Compensation: 7.7M
Compensation as of Fiscal Year 2014.

j.b. chemicals & pharma ltd (JBCP) Key Developments

J. B. Chemicals & Pharmaceuticals Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2015 and Consolidated Earnings Results for the Year Ended March 31, 2015

J. B. Chemicals & Pharmaceuticals Ltd. reported audited standalone earnings results for the fourth quarter and year ended March 31, 2015 and consolidated earnings results for the year ended March 31, 2015. For the quarter, on standalone basis, the company reported net sales of INR 2,497.6 million compared to INR 2,236.1 million a year ago. Total revenue was INR 2,565.9 million compared to INR 2,369.6 million a year ago. Operating profit was INR 346.3 million compared to INR 116.0 million a year ago. Profit before tax was INR 387.3 million compared to INR 249.5 million a year ago. Profit after tax was INR 257.3 million compared to INR 214.3 million a year ago. EPS was INR 3.03 compared to INR 2.53 a year ago. For the year, the company reported net sales of INR 10,381.4 million compared to INR 9,344.3 million a year ago. Total revenue was INR 10,718.3 million compared to INR 9,940.7 million a year ago. Operating profit was INR 1,590.8 million compared to INR 1,229.3 million a year ago. Profit before tax was INR 1,591.0 million compared to INR 939.9 million a year ago. Profit after tax was INR 1,135.8 million compared to INR 684.3 million a year ago. EPS was INR 13.39 compared to INR 8.07 a year ago. For the year, on consolidated basis, the company reported net sales of INR 11,206.6 million compared to INR 10,006.3 million a year ago. Total revenue was INR 11,551.0 million compared to INR 10,595.6 million a year ago. Operating profit was INR 1,541.4 million compared to INR 1,204.0 million a year ago. Profit before tax was INR 1,455.5 million compared to INR 874.4 million a year ago. Profit after tax was INR 1,004.0 million compared to INR 615.0 million a year ago. EPS was INR 11.84 compared to INR 7.26 a year ago.

J. B. Chemicals & Pharmaceuticals Ltd. Recommends Special and Regular Dividend for the Year 2014-2015, Payable on August 13, 2015

J. B. Chemicals & Pharmaceuticals Ltd. announced that the board of directors of the company at its meeting held on May 20, 2015, has recommended dividend of INR 14 per equity share of face value of INR 2 comprising of special dividend of INR 10 per equity share and regular dividend of INR 4 per equity share for the year 2014-2015. The dividend if declared, will be paid/dispatched on August 13, 2015.

J. B. Chemicals & Pharmaceuticals Ltd. to Report Fiscal Year 2015 Results on May 20, 2015

J. B. Chemicals & Pharmaceuticals Ltd. announced that they will report fiscal year 2015 results on May 20, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBCP:IN 237.50 INR -2.00

JBCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBCP.
View Industry Companies
 

Industry Analysis

JBCP

Industry Average

Valuation JBCP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact J.B. CHEMICALS & PHARMA LTD, please visit www.jbcpl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.